Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 923
Guide Official Revision Description Reason for Update
Version Date Number Of Change
protocol, and pharmaceutical
considerations.
2011 09/12/11 3. Administrative In Table of Contents,
renumber entries listed on
pages iii and iv.
2011 08/12/11 1. Medical Policy In Special Issuances, Third-
Class AME Assisted – Valve
Replacement, revise to
include additional criteria for
deferral (“the applicant
develops emboli, thrombosis,
etc.”).
2011 08/12/11 2. Medical Policy In Special Issuances, AME
Assisted – All Classes –
Atrial Fibrillation, revise to
include additional criteria for
deferral (“bleeding that
required medical
intervention”).
2011 08/12/11 3. Medical Policy In Special Issuances, AME
Assisted – All Classes –
Warfarin (Coumadin)
Therapy for Deep Venous
Thrombosis (DVT),
Pulmonary Embolism (PE),
and/ or
Hypercouagulopathies,
revise to include additional
criteria for deferral (“bleeding
that required medical
intervention”).
2011 08/12/11 4. Medical Policy In Special Issuances, Third-
Class AME Assisted –
Coronary Heart Disease,
revise to include additional
criteria for deferral (“bleeding
that required medical
intervention”).
2011 08/09/11 1. Medical Policy In Disease Protocols,
Coronary Heart Disease,
correct in item A.1.b.,
“replacement” to “repair.”
2011 08/09/11 2. Administrative In Pharmaceuticals –
Antihypertensive, revise to
clarify unacceptable
medications.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
